Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial Meeting Abstract
| Authors: | Park, J. O.; Meng, D. T. W.; Hollebecque, A.; Borad, M.; Goyal, L.; Schram, A.; Cassier, P.; Kamath, S. D.; Dotan, E.; Kim, R.; Sahai, V.; Liao, C. Y.; Millward, M.; Perez, D. R.; Blakesley, R.; Wolf, B.; Subbiah, V.; Kelley, R. K.; Oh, D. Y. |
| Abstract Title: | Efficacy of RLY-4008, a highly selective FGFR2 inhibitor in patients (pts) with an FGFR2-fusion or rearrangement (f/r), FGFR inhibitor (FGFRi)-naïve cholangiocarcinoma (CCA): ReFocus trial |
| Meeting Title: | ESMO Asia Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2022 Dec 2-4 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-11-01 |
| Start Page: | S1461 |
| End Page: | S1462 |
| Language: | English |
| ACCESSION: | WOS:000897943700078 |
| DOI: | 10.1016/j.annonc.2022.10.112 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 76MO -- Source: Wos |
